Titanocene Y and Vanadocene Y: Platinum Resistance-Breaking Cytotoxic and DNA-Targeting Anticancer Drug Candidates

E-ISSN： 1875-628x|8|10|904-910

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.10, 2011-12, pp. : 904-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Titanocene Y - Transport and Targeting of an Anticancer Drug Candidate

Letters in Drug Design & Discovery, Vol. 10, Iss. 8, 2013-10 ,pp. : 675-682

Bentham Science Publishers

Access to resources Recommend Favorite

The Interaction of Titanocene Y with Double-Stranded DNA: A Computational Study

Letters in Drug Design & Discovery, Vol. 5, Iss. 5, 2008-07 ,pp. : 332-335

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer Drug Discovery Targeting DNA Hypermethylation

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1350-1375

Bentham Science Publishers

Access to resources Recommend Favorite

The Antiangiogenic and Antitumoral Activity of Titanocene Y* In Vivo

Letters in Drug Design & Discovery, Vol. 8, Iss. 4, 2011-05 ,pp. : 302-307

Bentham Science Publishers

Access to resources Recommend Favorite

The Cytotoxicity of Titanocene Y Against CAKI-1 Cells: An In Vitro Formulation Study

Letters in Drug Design & Discovery, Vol. 7, Iss. 5, 2010-01 ,pp. : 310-317

Bentham Science Publishers

Access to resources Recommend Favorite